Alector, Inc. - Common Stock (NQ:ALEC)

1.990 +0.180 (+9.94%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 30 ↗

November 30, 2024

Via Talk Markets

Topics Stocks / Equities

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views ↗

November 26, 2024

Via Benzinga

Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results ↗

November 26, 2024

Via Benzinga

Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce ↗

November 26, 2024

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.

Via Benzinga

Recap: Alector Q4 Earnings ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

US Stocks Mixed; Best Buy Posts Downbeat Earnings ↗

November 26, 2024

Via Benzinga

Leslie's Posts Weak Results, Joins Zoom Video And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket ↗

November 26, 2024

Via Benzinga

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

November 25, 2024

From Alector, Inc.

Via GlobeNewswire

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

November 14, 2024

From Alector, Inc.

Via GlobeNewswire

Alector Reports Third Quarter 2024 Financial Results and Provides Business Update

November 06, 2024

From Alector, Inc.

Via GlobeNewswire

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

September 19, 2024

From Alector, Inc.

Via GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

August 29, 2024

From Alector, Inc.

Via GlobeNewswire

Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

August 07, 2024

From Alector, Inc.

Via GlobeNewswire

Alector to Host Mid-Year Earnings Conference Call

July 31, 2024

Call Scheduled for Wednesday, August 7, 2024, at 4:30 p.m. ET/1:30 p.m. PT

From Alector, Inc.

Via GlobeNewswire

Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)

July 28, 2024

From Alector, Inc.

Via GlobeNewswire

Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024

July 23, 2024

From Alector, Inc.

Via GlobeNewswire

Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

June 20, 2024

From Alector, Inc.

Via GlobeNewswire

Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 10, 2024

Via Benzinga

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

June 10, 2024

Leading scientific expert to provide insights into emerging technologies for blood-brain barrier modulation

From Alector, Inc.

Via GlobeNewswire

Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

June 03, 2024

From Alector, Inc.

Via GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

May 09, 2024

From Alector, Inc.

Via GlobeNewswire

ALEC Stock Earnings: Alector Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

ALEC stock results show that Alector beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Alector Reports First Quarter 2024 Financial Results and Provides Business Update

May 08, 2024

From Alector, Inc.

Via GlobeNewswire

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback ↗

March 28, 2024

The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 06, 2024

We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!

Via InvestorPlace

Alector to Participate in Upcoming Healthcare Conferences

February 28, 2024

From Alector, Inc.

Via GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

February 27, 2024

From Alector, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.